Latest articles: Thursday 12th December 2019 The National Cancer Diagnosis Audit found that 34% of stomach cancer diagnoses had avoidable delays. This course is developed with and for primary care professionals to look at the different ways to assess and manage a...
Latest articles: Proton Pump Inhibitors (PPIs) are widely used to treat acid reflux and dyspepsia. NICE cautions that PPIs can mask or alter symptoms of stomach cancer, leading to later diagnoses. Potential Pitfall Patients on PPIs who have developed stomach cancer...
FIT vs gFOBTs: What’s changed?
Friday 18th October 2019
The new Faecal Immunochemical Test (FIT) rolled out across England this year has a number of benefits in replacing the use of older guaiac-based faecal occult blood tests (gFOBTs). Is your practice up to date with the new processes associated with FIT and are you aware of the reasons for the change?
Our latest course on Faecal Immunochemical Testing (FIT) is now available, outlining the use of FIT as a screening tool and appropriate use for symptomatic patients. It also includes some of the key benefits of changing to this method from gFOBTs, including:
- Increased reliability as an indicator of abnormal pathology
- The need for one patient sample only, compared to the previous three
- Using antibodies that specifically recognise human haemoglobin
- Reducing the number of repeat tests, as there are no borderline results (only normal or abnormal)
Find out more:
Find out more: visit the GatewayC Faecal Immunochemical Test course here. 1 CPD credit is available upon completion of this course.